VX19-445-107: A Phase 3, Open-label Study Evaluating theLong-term Safety and Efficacy of VX-445/TEZ/IVACombination Therapy in Subjects With CysticFibrosis Who Are 6 Years of Age and Older

Project: Research project

Project Details

StatusActive
Effective start/end date2/19/20 → 8/31/50

Funding

  • Vertex Pharmaceuticals Incorporated
  • Ann & Robert H. Lurie Children's Hospital of Chicago